Who are the stem cell elves? Merry Christmas! You heard me, Merry Christmas! I’m a Democrat and I love Christmas! As we think about the holiday season, it seems appropriate to make our list, just as Santa is doing, of the elves and grinches of the stem cell world. For today on Christmas, let’s forget the […]
Your definitive Christmas list of stem cell elves Read More »
Earlier this year we found out that Texas Governor and GOP Presidential hopeful, Rick Perry, had received a stem cell transplant. You can read more about this here. The details of Perry’s transplant remain somewhat obscure, but as best as we can tell he received the transplant here in the U.S., most likely in Houston,
Did Stem Cells Ruin Rick Perry’s Chances to Be President? Read More »
Last year around this time I presented my first stem cell awards of the year, in that case for 2010. You can see whom I thought deserved awards here. Now it is time for our 2011 stem cell awards. These awards reflect my opinions and those not mentioned will hopefully forgive me as there is
Stem Cell Awards for 2011 Read More »
A year from now will I still be conducted federally funded research on human ES cells? What about the hundreds of other professors in the U.S. and their thousands of employees? It is not unreasonable at this point to forecast a perfect storm in Fall 2012 that may kill elements of stem cell research that
The perfect storm in Fall 2012 that may kill ES cells research Read More »
Each year at this time I start thinking about what the next year will bring for the stem cell field and make predictions. This year is no different and I’ve been pondering what 2012 has in store for us. You can read my predictions for 2011 here and see how I fared. Not too bad, but overly optimistic
Stem cell predictions for 2012: Science, CIRM, ACT, trends Read More »
Yesterday Geron announced it would be immediately stopping its stem cell research program. What does this mean? While this program has (or should I say “had”) a number of elements, at its heart was of course its hESC-based OPC drug (GRNOPC1) for spinal cord injury, which was in an FDA-approved Phase I Clinical Trial that
The day after Geron news: a realistic outlook for the stem cell field Read More »
Many of you may have heard that there is a Vatican stem cell meeting . Today the Vatican held the first day of its adult stem cell conference. Embryonic stem cells remained not surprisingly uninvited. This conference is an unprecedented event in the thousands of years of history of The Church so not surprisingly many
What are the goals of the Vatican stem cell meeting and why no press releases so far? Read More »
What with the Mississippi “personhood” amendment up for a vote today and also the Vatican Adult Stem Cell Conference beginning tomorrow, I thought today was a good time for a post about adult versus embryonic stem cells. Does stem cell research have to be either/or? Adult or stem? Can’t someone be for both adult and
Key points about adult versus embryonic stem cells Read More »
What is Myc? Often when we dig a little into the science of stem cells, people get turned off by all the strange names of molecules and jargon. However, whether you are a scientist, patient, investor, reporter, etc. there are some aspects of stem cell science that are ‘musts’ to know about. For example, you
Want to understand stem cells? Then you have to know Myc Read More »
As many of you know, I did a post this week on an article in The New Scientist that many readers had complained to me about. Their concerns and mine as well centered on two points. First, the article seemed at a factual level to be confusing and written in a People Magazine-esque style that
More on The New Scientist and stem cells Read More »